Roger Grissom Rn, Bsn, MBA
About Roger Grissom Rn, Bsn, MBA
Roger Grissom, RN, BSN, MBA, is an Executive Territory Business Manager at Bristol Myers Squibb with extensive experience in oncology and hematology sales and management.
Title
Roger Grissom currently holds the title of Executive Territory Business Manager at Bristol Myers Squibb, covering areas including Western/Central Massachusetts, Southeastern Massachusetts, Rhode Island, and Greater Hartford, Connecticut.
Current Role at Bristol Myers Squibb
Roger Grissom serves as an Executive Territory Business Manager at Bristol Myers Squibb. His responsibilities encompass the Western/Central MA, Southeastern MA, Rhode Island, and Greater Hartford, CT regions. Additionally, he is an Executive Board Member and Chair of the Sales Leadership Society at the same company, demonstrating his leadership acumen in the field.
Previous Positions
Roger Grissom has held key positions in various prominent companies. He worked as a Senior Territory Business Manager at Bristol Myers Squibb from 2019 to 2022, managing territories similar to his current role. At Biogen Idec, Inc., he was the Area Business Manager for Oncology/Hematology in the Boston/Providence region from 2009 to 2011. His experience includes a long tenure at Celgene from 2011 to 2019, where he was a Senior Hematology Oncology Consultant. He also served as Senior Executive Oncology Account Manager at GlaxoSmithKline, Inc for 11 years and Project Manager Oncology and Acute Care: Commercial Analysis for one year.
Education and Expertise
Roger Grissom holds a Bachelor of Science in Nursing (BSN) from the University of Rhode Island (1991-1996) and a Master of Business Administration (MBA) from their College of Business (2004-2008). This unique combination of medical and business education provides him with a diverse perspective on healthcare and business operations. His expertise covers a wide range of oncology and hematology conditions such as Non-Hodgkin’s Lymphoma, Multiple Myeloma, Acute Myeloid Leukemia (AML), and more. He also possesses knowledge in drug therapies including CAR T-Cell Therapy, radioimmunotherapy, and chemotherapy.
Professional Achievements
With a broad-based biotech and pharmaceutical sales experience spanning 24 years, Roger Grissom has a proven track record of successfully launching new drugs and penetrating markets. His expertise includes drug therapy in CAR T-Cell Therapy, radioimmunotherapy, chemotherapy, antitumor antibiotics, and disease-modifying agents. He has consistently increased sales by employing effective selling strategies, market development, and employing business intelligence. His skills extend to sales training, managed care, market research, and developing high-performing teams, further emphasized by his effective management of key hospital relationships.